| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A randomized phase 2 study of HLX22 plus trastuzumab biosimilar HLX02 and XELOX as first-line therapy for HER2-positive advanced gastric cancer
|
Li, Ning
|
|
|
5 |
10 |
p. 1255-1265.e2
|
artikel
|
| 2 |
Dual HER2 inhibition: Is two better than one?
|
Strickland, Matthew R.
|
|
|
5 |
10 |
p. 1191-1193
|
artikel
|
| 3 |
Efficacy, immunogenicity, and safety of a monovalent mRNA vaccine, ABO1020, in adults: A randomized, double-blind, placebo-controlled, phase 3 trial
|
Hannawi, Suad
|
|
|
5 |
10 |
p. 1282-1292.e3
|
artikel
|
| 4 |
Expanding the frontiers of therapeutic options in hidradenitis suppurativa: The valid contribution of bimekizumab
|
Molinelli, Elisa
|
|
|
5 |
10 |
p. 1197-1199
|
artikel
|
| 5 |
Fluid biomarkers in the context of amyloid-targeting disease-modifying treatments in Alzheimer’s disease
|
Hu, Yan
|
|
|
5 |
10 |
p. 1206-1226
|
artikel
|
| 6 |
Global burden and management of women with epilepsy in pregnancy: A modeling study
|
Sha, Leihao
|
|
|
5 |
10 |
p. 1326-1333.e4
|
artikel
|
| 7 |
Gut microbiome model predicts response to neoadjuvant immunotherapy plus chemoradiotherapy in rectal cancer
|
Yang, Zhengyang
|
|
|
5 |
10 |
p. 1293-1306.e4
|
artikel
|
| 8 |
NanoRanger enables rapid single-base-pair resolution of genomic disorders
|
Zhang, Yingzi
|
|
|
5 |
10 |
p. 1307-1325.e3
|
artikel
|
| 9 |
Phenotypic subgroup in serologically active clinically quiescent systemic lupus erythematosus: A cluster analysis based on CSTAR cohort
|
Ding, Yufang
|
|
|
5 |
10 |
p. 1266-1274.e3
|
artikel
|
| 10 |
Preclinical assessment for translation to humans: The PATH approach for assessing supporting evidence for early-phase trials and innovative care
|
Kimmelman, Jonathan
|
|
|
5 |
10 |
p. 1227-1236
|
artikel
|
| 11 |
Preclinical study and phase II trial of adapting low-dose radiotherapy to immunotherapy in small cell lung cancer
|
Wang, Hui
|
|
|
5 |
10 |
p. 1237-1254.e9
|
artikel
|
| 12 |
Treatment of chronic hand eczema with topical anti-inflammatory drugs other than topical corticosteroids
|
Saeki, Hidehisa
|
|
|
5 |
10 |
p. 1203-1205
|
artikel
|
| 13 |
Trofinetide for the treatment of Rett syndrome: Long-term safety and efficacy results of the 32-month, open-label LILAC-2 study
|
Percy, Alan K.
|
|
|
5 |
10 |
p. 1275-1281.e2
|
artikel
|
| 14 |
Trofinetide treatment for Rett syndrome: Lessons to learn
|
Tropea, Daniela
|
|
|
5 |
10 |
p. 1194-1196
|
artikel
|
| 15 |
Twice-yearly lenacapavir: A milestone for HIV prevention in young African women
|
Nozza, Silvia
|
|
|
5 |
10 |
p. 1200-1202
|
artikel
|
Tijdschrift beschrijving